Hikma Pharmaceuticals (UK) Profile

1,408
GBp 22.5  1.57%
71%
52%

Hikma Pharmaceuticals Summary

Hikma Pharmaceuticals PLC (HIK) is traded on London Stock Exchange in UK. It is located in 1 New Burlington Place and employs 8,500 people. The company currently falls under 'Mid-Cap' category with current market capitalization of 3.37 B. Hikma Pharmaceuticals PLC classifies itself under Healthcare sector and is part of Pharmaceuticals And Biosciences industry. This company has 240.89 M outstanding shares. HIKMA PHARM has accumulated about 227 M in cash with 443 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.95.
Check Hikma Pharmaceuticals Probability Of Bankruptcy

Target Price Odds Analysis

Odds Below 1407.5HorizonTargetOdds Above 1407.5
76.92%30 days 1,408 22.71%
Based on normal probability distribution, the odds of Hikma Pharmaceuticals to move above current price in 30 days from now is about 22.71% (This Hikma Pharmaceuticals PLC probability density function shows the probability of Hikma Pharmaceuticals Stock to fall within a particular range of prices over 30 days) .

Top Holders

Hikma Pharmaceuticals Risk Profiles

Key Fundamentals

Hikma Pharmaceuticals Against Markets

Current Ratings

Hikma Pharmaceuticals 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
11 
Chance of
Financial Distress (0 to 100%)
22 
Equity ratings for Hikma Pharmaceuticals PLC are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Hikma Pharmaceuticals PLC develops, manufactures, and markets a range of generic, branded, and in-licensed pharmaceutical products in solid, semi-solid, liquid, and injectable final dosage forms worldwide. Hikma Pharmaceuticals PLC was founded in 1978 and is based in London, the United Kingdom. Hikma Pharmaceuticals operates under Drug Manufacturers - Specialty Generic classification in UK and traded on London Stock Exchange. It employs 8500 people. more
NameHikma Pharmaceuticals PLC
President and CEO, USAMichael RayaView All
Thematic Classification
Currently Active Investing Idea
  Healthcare
View All
Macroaxis Advice
Specialization
Healthcare, Pharmaceuticals And Biosciences
InstrumentUK Stock View All
Business Address1 New Burlington Place
ExchangeLondon Stock Exchange
ISINGB00B0LCW083
SectorHealthcare
IndustryPharmaceuticals And Biosciences
BenchmarkDOW
Websitewww.hikma.com
Contact Number44 20 7399 2760
CurrencyGBp

Diversify with Hikma Pharmaceuticals PLC

Build Optimal Portfolios
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Hikma Pharmaceuticals PLC to your portfolio

Directors

Hikma Pharmaceuticals Corporate Directors
Pamela Kirby Non-Executive Independent Director, Ph.D
John Castellani Non-Executive Independent Director
Ali AlHusry Non-Executive Director, MBA
Please also check Risk vs Return Analysis. Please also try Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.